These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29848318)

  • 1. Malignant adnexal tumors of the skin: a single institution experience.
    Oyasiji T; Tan W; Kane J; Skitzki J; Francescutti V; Salerno K; Khushalani NI
    World J Surg Oncol; 2018 May; 16(1):99. PubMed ID: 29848318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: risk factors and trends in outcomes.
    Avraham JB; Villines D; Maker VK; August C; Maker AV
    J Surg Oncol; 2013 Jul; 108(1):57-62. PubMed ID: 23677677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare tumors through the looking glass: an examination of malignant cutaneous adnexal tumors.
    Martinez SR; Barr KL; Canter RJ
    Arch Dermatol; 2011 Sep; 147(9):1058-62. PubMed ID: 21931043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck.
    Wang LS; Handorf EA; Wu H; Liu JC; Perlis CS; Galloway TJ
    Am J Clin Oncol; 2017 Aug; 40(4):429-432. PubMed ID: 25599317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of lymph node involvement in malignant cutaneous adnexal tumors.
    Barnes M; Hestley A; Murray DR; Carlson GW; Parker D; Delman KA
    Am Surg; 2014 Mar; 80(3):270-4. PubMed ID: 24666868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior of Cutaneous Adnexal Malignancies: a Single Institution Experience.
    Prieto-Granada C; Castner N; Chen A; Li J; Yue B; Wong JY; Iyengar S; Sondak VK; Zager JS; Messina JL
    Pathol Oncol Res; 2020 Jan; 26(1):239-244. PubMed ID: 29948620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depth and Patterns of Adnexal Involvement in Primary Extramammary (Anogenital) Paget Disease: A Study of 178 Lesions From 146 Patients.
    Konstantinova AM; Shelekhova KV; Stewart CJ; Spagnolo DV; Kutzner H; Kacerovska D; Plaza JA; Suster S; Bouda J; Pavlovsky M; Kyrpychova L; Michal M; Guenova E; Kazakov DV
    Am J Dermatopathol; 2016 Nov; 38(11):802-808. PubMed ID: 26863064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective study of rare cutaneous malignant adnexal tumors of the head and neck in a tertiary care cancer hospital: a case series.
    Waqas O; Faisal M; Haider I; Amjad A; Jamshed A; Hussain R
    J Med Case Rep; 2017 Mar; 11(1):67. PubMed ID: 28284233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management and lymph-node biopsy of rare malignant cutaneous adnexal carcinomas: a population-based analysis of 7591 patients.
    Goyal A; Marghitu T; Goyal N; Rubin N; Patel K; Goyal K; O'Leary D; Bohjanen K; Maher I
    Arch Dermatol Res; 2021 Oct; 313(8):623-632. PubMed ID: 32965516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival outcomes for head and neck cutaneous adnexal cancers.
    Jandali DB; Ganti A; Al-Khudari S; Tajudeen BA; Revenaugh PC
    Am J Otolaryngol; 2019; 40(1):110-114. PubMed ID: 30472120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients.
    Wong TY; Suster S; Nogita T; Duncan LM; Dickersin RG; Mihm MC
    Cancer; 1994 Mar; 73(6):1631-43. PubMed ID: 7512435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study.
    Ganly I; Patel SG; Singh B; Kraus DH; Bridger PG; Cantu G; Cheesman A; De Sa G; Donald P; Fliss DM; Gullane P; Janecka I; Kamata SE; Kowalski LP; Levine PA; Medina dos Santos LR; Pradhan S; Schramm V; Snyderman C; Wei WI; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):73-8. PubMed ID: 16415433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes and patterns of failure in women with stage IIIC
    Lee JK; Mahan M; Hanna RK; Elshaikh MA
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():192-197. PubMed ID: 28800504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiosarcoma of the scalp and face: the Mayo Clinic experience.
    Patel SH; Hayden RE; Hinni ML; Wong WW; Foote RL; Milani S; Wu Q; Ko SJ; Halyard MY
    JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):335-40. PubMed ID: 25634014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adnexal skin tumors in Zaria, Nigeria.
    Samaila MO
    Ann Afr Med; 2008 Mar; 7(1):6-10. PubMed ID: 18702242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous mixed tumor, eccrine variant: a clinicopathologic and immunohistochemical study of 50 cases, with emphasis on unusual histopathologic features.
    Kazakov DV; Kacerovska D; Hantschke M; Zelger B; Kutzner H; Requena L; Grayson W; Bisceglia M; Schaller J; Kempf W; Denisjuk N; Michal M
    Am J Dermatopathol; 2011 Aug; 33(6):557-68. PubMed ID: 21697702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Skin adnexal tumors: Histological study about 96 cases].
    El Ochi MR; Boudhas A; Allaoui M; Rharrassi I; Chahdi H; Al Bouzidi A; Oukabli M
    Pan Afr Med J; 2015; 20():389. PubMed ID: 26185579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy and chemotherapy in malignant sweat gland tumors.
    Whittington R; Browning ME; Farrell GR; Miremadi A
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 2):1093-7. PubMed ID: 3771857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eccrine sweat gland carcinoma of the skin].
    Rütten A
    Pathologe; 2002 Jan; 23(1):79-88. PubMed ID: 11974507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.